Childhood Acute Lymphoblastic Leukemia in Remission

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Childhood Acute Lymphoblastic Leukemia in Remission trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05809284

Determining the Mechanisms of Loss of CAR T Cell Persistence

A prospective observational study of pediatric and young adult acute lymphoblastic leukaemia (ALL) patients treated with CD19 chimeric antigen receptor T-cells…

United Kingdom50 participantsStarted 2023-10-18

All recent trials (100 shown)

Not Yet RecruitingNot Applicable

NCT07374315

Weight Gain in Pediatric Leukemia Survivors

This is a trial assessing the efficacy of two weight maintenance programs for children with acute lymphoblastic leukemia (ALL) and the patients' caregivers. Pat…

United States80 participantsStarted 2026-05-31

Treatment: Modified Guided Self-Help Family Intervention, NIH Educational Resources

CompletedPhase 1

NCT01279096

Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia

The purpose of this study is to determine Maximum Tolerated Dosage (MTD), Dosage Limited Toxicities (DLT), and the Rate Phase 2 Dosage of clofarabine when used…

France20 participantsStarted 2010-01

Treatment: Clofarabine

Childhood Acute Lymphoblastic Leukemia in Remission

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Determining the Mechanisms of Loss of CAR T Cell Persistence

All recent trials (100 shown)

Weight Gain in Pediatric Leukemia Survivors

Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Determining the Mechanisms of Loss of CAR T Cell Persistence

All recent trials (100 shown)

Weight Gain in Pediatric Leukemia Survivors

Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remiss…

Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies

CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL

Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia

Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic…

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Un…

Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplan…

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children

Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Tr…

Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acut…

Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia

Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or…

DNA Analysis of Tumor Tissue Samples From Young Patients With Acute Lymphoblastic Leukemia

Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia